{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T17:56:59Z","timestamp":1793469419982,"version":"4.5.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008658","name":"German Cancer Research Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008658","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000046","name":"National Research Council Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000046","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009647","name":"Ministry of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009647","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008001","name":"University of Cologne","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Forschung, Technologie und Raumfahrt","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.ebiom.2025.106057","type":"journal-article","created":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T23:46:20Z","timestamp":1765496780000},"page":"106057","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Evaluation of an HPV16-L1 antibody rapid test for oropharyngeal cancer diagnosis: diagnostic accuracy and challenges in real-world settings"],"prefix":"10.1016","volume":"123","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2509-1661","authenticated-orcid":false,"given":"Johannes M.A.","family":"Kusters","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Brenner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3389-5141","authenticated-orcid":false,"given":"Johannes A.","family":"Bogaards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9555-3876","authenticated-orcid":false,"given":"Steffi","family":"Silling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariam","family":"El-Zein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9065-4734","authenticated-orcid":false,"given":"Penelope","family":"Gray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"Kann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo L.","family":"Franco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matti","family":"Lehtinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Dietz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Laban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8223-7954","authenticated-orcid":false,"given":"Jens Peter","family":"Klussmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrike","family":"Wieland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Waterboer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ebiom.2025.106057_bib1","first-page":"80","article-title":"Review of HPV-related diseases and cancers","volume":"40","author":"Brianti","year":"2017","journal-title":"New Microbiol"},{"issue":"4","key":"10.1016\/j.ebiom.2025.106057_bib2","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S1470-2045(09)70096-8","article-title":"A review of human carcinogens\u2014Part B: biological agents","volume":"10","author":"Bouvard","year":"2009","journal-title":"Lancet Oncol"},{"issue":"2","key":"10.1016\/j.ebiom.2025.106057_bib3","doi-asserted-by":"crossref","first-page":"e180","DOI":"10.1016\/S2214-109X(19)30488-7","article-title":"Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis","volume":"8","author":"de Martel","year":"2020","journal-title":"Lancet Glob Health"},{"issue":"10318","key":"10.1016\/j.ebiom.2025.106057_bib4","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1016\/S0140-6736(21)01550-6","article-title":"Head and neck cancer","volume":"398","author":"Mody","year":"2021","journal-title":"The Lancet"},{"key":"10.1016\/j.ebiom.2025.106057_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.oraloncology.2020.105177","article-title":"Global incidence trends in head and neck cancer for HPV-related and-unrelated subsites: a systematic review of population-based studies","volume":"115","author":"Menezes","year":"2021","journal-title":"Oral Oncol"},{"issue":"14","key":"10.1016\/j.ebiom.2025.106057_bib6","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1056\/NEJMoa1917338","article-title":"HPV vaccination and the risk of invasive cervical cancer","volume":"383","author":"Lei","year":"2020","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.ebiom.2025.106057_bib7","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1111\/coa.13817","article-title":"Tracking changes in age distribution of head and neck cancer in the United States from 1975 to 2016","volume":"46","author":"Bajpai","year":"2021","journal-title":"Clin Otolaryngol"},{"key":"10.1016\/j.ebiom.2025.106057_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.ypmed.2020.106399","article-title":"HPV vaccination introduction worldwide and WHO and UNICEF estimates of national HPV immunization coverage 2010\u20132019","volume":"144","author":"Bruni","year":"2021","journal-title":"Prev Med"},{"issue":"8","key":"10.1016\/j.ebiom.2025.106057_bib9","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/s41388-023-02927-9","article-title":"HPV-associated oropharyngeal cancer: in search of surrogate biomarkers for early lesions","volume":"43","author":"Lim","year":"2024","journal-title":"Oncogene"},{"key":"10.1016\/j.ebiom.2025.106057_bib10","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/2046-4053-2-35","article-title":"Screening for cervical cancer: a systematic review and meta-analysis","volume":"2","author":"Peirson","year":"2013","journal-title":"Syst Rev"},{"issue":"102804","key":"10.1016\/j.ebiom.2025.106057_bib11","article-title":"DRH1\u2013a novel blood-based HPV tumour marker","volume":"56","author":"Weiland","year":"2020","journal-title":"EBioMedicine"},{"issue":"5","key":"10.1016\/j.ebiom.2025.106057_bib12","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1007\/s00405-024-08537-9","article-title":"Detection of antibody subclasses IgA, IgM and IgG against HPV L1 in HPV-positive oropharyngeal squamous cell carcinoma patients: a pilot study","volume":"281","author":"Weiland","year":"2024","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1016\/j.ebiom.2025.106057_bib13","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.cbpa.2016.03.001","article-title":"Prevention of cervical cancer: journey to develop the first human papillomavirus virus-like particle vaccine and the next generation vaccine","volume":"32","author":"Bryan","year":"2016","journal-title":"Curr Opin Chem Biol"},{"key":"10.1016\/j.ebiom.2025.106057_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.tvr.2022.200245","article-title":"HPV and head and neck cancers: towards early diagnosis and prevention","volume":"14","author":"Galati","year":"2022","journal-title":"Tumour Virus Res"},{"issue":"10","key":"10.1016\/j.ebiom.2025.106057_bib15","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1002\/ijc.28888","article-title":"Antibodies against high-risk human papillomavirus proteins as markers for invasive cervical cancer","volume":"135","author":"Combes","year":"2014","journal-title":"Int J Cancer"},{"issue":"12","key":"10.1016\/j.ebiom.2025.106057_bib16","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.3390\/cancers13123010","article-title":"Sensitivity and specificity of human papillomavirus (HPV) 16 early antigen serology for HPV-driven oropharyngeal cancer: a systematic literature review and meta-analysis","volume":"13","author":"Hibbert","year":"2021","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.ebiom.2025.106057_bib17","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/s41541-020-0165-x","article-title":"Peak neutralizing and cross-neutralizing antibody levels to human papillomavirus types 6\/16\/18\/31\/33\/45\/52\/58 induced by bivalent and quadrivalent HPV vaccines","volume":"5","author":"Mariz","year":"2020","journal-title":"npj Vaccines"},{"issue":"Pt 7","key":"10.1016\/j.ebiom.2025.106057_bib18","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1099\/vir.0.019349-0","article-title":"Validation of multiplexed human papillomavirus serology using pseudovirions bound to heparin-coated beads","volume":"91","author":"Faust","year":"2010","journal-title":"J Gen Virol"},{"issue":"1","key":"10.1016\/j.ebiom.2025.106057_bib19","doi-asserted-by":"crossref","DOI":"10.2196\/11284","article-title":"Human papillomavirus infection and transmission among couples through heterosexual activity (HITCH) cohort study: protocol describing design, methods, and research goals","volume":"8","author":"El-Zein","year":"2019","journal-title":"JMIR Res Protoc"},{"key":"10.1016\/j.ebiom.2025.106057_bib20","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/1471-2334-14-120","article-title":"Glutathione S-transferase L1 multiplex serology as a measure of cumulative infection with human papillomavirus","volume":"14","author":"Robbins","year":"2014","journal-title":"BMC Infect Dis"},{"issue":"10","key":"10.1016\/j.ebiom.2025.106057_bib21","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1373\/clinchem.2005.052381","article-title":"Multiplex human papillomavirus serology based on in situ\u2013purified glutathione S-transferase fusion proteins","volume":"51","author":"Waterboer","year":"2005","journal-title":"Clin Chem"},{"issue":"3","key":"10.1016\/j.ebiom.2025.106057_bib22","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1148\/radiol.2015151516","article-title":"Stard 2015: an updated list of essential items for reporting diagnostic accuracy studies","volume":"277","author":"Bossuyt","year":"2015","journal-title":"Radiology"},{"issue":"4","key":"10.1016\/j.ebiom.2025.106057_bib23","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1093\/infdis\/jiy545","article-title":"Long-term antibody response to human papillomavirus vaccines: up to 12 years of follow-up in the Finnish maternity cohort","volume":"219","author":"Artemchuk","year":"2019","journal-title":"J Infect Dis"},{"issue":"18","key":"10.1016\/j.ebiom.2025.106057_bib24","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1016\/j.vaccine.2019.03.052","article-title":"Durability of the neutralizing antibody response to vaccine and non-vaccine HPV types 7 years following immunization with either cervarix\u00ae or gardasil\u00ae vaccine","volume":"37","author":"Godi","year":"2019","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.ebiom.2025.106057_bib25","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.vaccine.2022.11.044","article-title":"Evaluation of immune response to single dose of quadrivalent HPV vaccine at 10-year post-vaccination","volume":"41","author":"Joshi","year":"2023","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.ebiom.2025.106057_bib26","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2021.1908059","article-title":"Review of long-term immunogenicity following HPV vaccination: gaps in current knowledge","volume":"18","author":"Hoes","year":"2022","journal-title":"Human vaccines & immunotherapeutics"},{"issue":"67","key":"10.1016\/j.ebiom.2025.106057_bib27","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1093\/jncimonographs\/lgae032","article-title":"HPV16\/18 antibodies 16-years after single dose of bivalent HPV vaccination: costa Rica HPV vaccine trial","volume":"2024","author":"Porras","year":"2024","journal-title":"JNCI Monographs"},{"issue":"12","key":"10.1016\/j.ebiom.2025.106057_bib28","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.1002\/ijc.30697","article-title":"Sensitivity and specificity of antibodies against HPV16 E6 and other early proteins for the detection of HPV16-driven oropharyngeal squamous cell carcinoma","volume":"140","author":"Holzinger","year":"2017","journal-title":"Int J Cancer"},{"issue":"31","key":"10.1016\/j.ebiom.2025.106057_bib29","doi-asserted-by":"crossref","first-page":"3613","DOI":"10.1200\/JCO.21.01785","article-title":"Absolute risk of oropharyngeal cancer after an HPV16-E6 serology test and potential implications for screening: results from the human papillomavirus cancer cohort consortium","volume":"40","author":"Robbins","year":"2022","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.ebiom.2025.106057_bib30","doi-asserted-by":"crossref","DOI":"10.1093\/jncics\/pky045","article-title":"Burden of human papillomavirus (HPV)-related cancers attributable to HPVs 6\/11\/16\/18\/31\/33\/45\/52 and 58","volume":"2","author":"de Sanjos\u00e9","year":"2019","journal-title":"JNCI Cancer Spectrum"},{"key":"10.1016\/j.ebiom.2025.106057_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.tvr.2022.200236","article-title":"Human papillomavirus seroprevalence and seroconversion following baseline detection of nine human papillomavirus types in young women","volume":"13","author":"Brown","year":"2022","journal-title":"Tumour Virus Res"},{"issue":"16","key":"10.1016\/j.ebiom.2025.106057_bib32","doi-asserted-by":"crossref","first-page":"4080","DOI":"10.3390\/cancers15164080","article-title":"Human papillomavirus-associated oropharyngeal cancer: global epidemiology and public policy implications","volume":"15","author":"Ndon","year":"2023","journal-title":"Cancers"},{"issue":"17","key":"10.1016\/j.ebiom.2025.106057_bib33","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1016\/j.vaccine.2021.03.047","article-title":"Oral and laryngeal HPV infection: incidence, prevalence and risk factors, with special regard to concurrent infection in head, neck and genitals","volume":"39","author":"Wierzbicka","year":"2021","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.ebiom.2025.106057_bib34","doi-asserted-by":"crossref","first-page":"e1345","DOI":"10.1016\/S2214-109X(23)00305-4","article-title":"Global and regional estimates of genital human papillomavirus prevalence among men: a systematic review and meta-analysis","volume":"11","author":"Bruni","year":"2023","journal-title":"Lancet Glob Health"},{"issue":"1","key":"10.1016\/j.ebiom.2025.106057_bib35","doi-asserted-by":"crossref","DOI":"10.1155\/2024\/6651272","article-title":"CER818: a highly specific and sensitive HPV L1 high-risk serological lateral flow rapid test for early detection of cervical cancer and its precursor lesions","volume":"2024","author":"Br\u00e4utigam","year":"2024","journal-title":"Infect Dis Obstet Gynecol"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396425005018?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396425005018?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T10:08:35Z","timestamp":1773914915000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396425005018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":35,"alternative-id":["S2352396425005018"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2025.106057","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of an HPV16-L1 antibody rapid test for oropharyngeal cancer diagnosis: diagnostic accuracy and challenges in real-world settings","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2025.106057","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106057"}}